Literature DB >> 3018114

Monocyte-derived growth factors for human tumor clonogenic cells.

A W Hamburger, C P White, K Lurie, R Kaplan.   

Abstract

Human peripheral blood monocytes secrete a soluble factor that enhances the ability of human epithelial tumor cell lines to clone in soft agar. Monocytes increased colony growth in a concentration-dependent manner, although inhibition of cell growth was observed in the presence of high concentrations of monocytes. Addition of indomethacin to monocytes did not abrogate this inhibition. Exposure of monocytes to endotoxin increased their ability to secrete stimulatory factors. Nonadherent lymphocytes were unable to support colony growth. Conditioned media from unstimulated monocytes also increased colony growth. Growth-promoting activity was detected in the media within the first 24 hr of culture, reaching a peak at 72 hr. Activity was not observed in monocyte lysates. Monocytes released this activity when cultured in the presence of both serum-free and serum-containing media. The activity was nondialyzable, relatively heat stable, and failed to adhere to CM-Sephadex. The demonstration of a monocyte-derived factor that enhances growth of epithelial tumor colonies supports findings indicating that inflammatory products may enhance tumor cell growth in vitro.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018114     DOI: 10.1002/jlb.40.4.381

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  2 in total

1.  Direct and indirect effects of recombinant human granulocyte-colony stimulating factor on in vitro colony formation of human bladder cancer cells.

Authors:  I A Shameem; H Kurisu; H Matsuyama; T Shimabukuro; K Naito
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

2.  Mesothelial cells stimulate the anchorage-independent growth of human ovarian tumour cells.

Authors:  A P Wilson
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.